Gopi Shanker
Chief Scientific Officer Beam Therapeutics
Gopi Shanker is the Chief Scientific Officer at Beam Therapeutics Inc., where he spearheads innovative research translating genetic insights into groundbreaking therapeutic strategies. With a profound understanding of human genetics, Dr. Shanker has been instrumental in advancing programs in hematology as well as liver genetic diseases. His work focuses on anchoring preclinical development to critical biomarkers, such as the 60/40 hemoglobin ratio in sickle cell disease, ensuring alignment with target product profiles. He is dedicated to optimizing therapeutic approaches from early-stage research through clinical trials, consistently demonstrating meaningful improvements in patient outcomes and successfully meeting registrational endpoints.
Seminars
- Anchoring preclinical programs on human genetic insights and the critical 60/40 hemoglobin ratio to optimize therapeutic development
- Optimizing therapeutic strategies by aligning preclinical endpoints with target product profiles to achieve meaningful clinical outcomes
- Achieving consistent 60/40 hemoglobin ratios in clinic, reducing painful vaso-occlusive crises to meet registrational endpoints
